Many players in the cosmetics industry offer product ranges which incorporate hemp (Cannabis sativa L.) and CBD.
The cannabis plant comprises hundreds of different substances, but the two best-known active ingredients in the plant are THC (delta-9-tetrahydrocannabinol) and CBD (cannabidiol).
Cannabis sativa, a botanical species which includes several varieties of hemp, are particularly distinguished by their THC and CBD contents, and are subject to strict control measures:
In a strict regulatory context, it is essential to select raw materials which are fully compliant in order to ensure the safety of the product and its efficiency. To achieve this, Eurofins supports customers at every key stage of the product development process, from:
[1] Regulation (CE) n°1223/2009
[2] Amended Order of 22 August 1990 implementing Article R. 5132-86 of the Public Health Code
[3] https://www.drogues.gouv.fr/actualites/cannabidiol-cbd-point-legislation
Read the entire ZOOM#18 : ZOOM#18-Microbiota-Preclinical-testing.web
Contact : cosmetics@eurofins.com
LIVE & HYBRID All you need to know about preclinical and clinical testing is at…
Abstract Background Oxidative stress is a significant factor in skin aging and pigmentation, which can be precipitated…
Remote prescribing of cosmetic injectables is set to be banned within weeks in a landmark…